Lab Due Diligence: 12 Operational Red Flags PE Buyers Miss

Testing laboratory being reviewed during private equity operational due diligence

Key takeaways: Financial diligence on a testing or QC lab rarely shows its operational risk. Accreditation scope, instrument condition, data integrity and key-person dependency can each erase value after close. A two-week operational review using the 12 checks below surfaces most of it before signing.

Testing, inspection and certification labs and outsourced QC labs are attractive targets: recurring revenue, regulatory moats and fragmented markets ripe for roll-ups. But a lab's value sits on assets the financial model barely sees, such as its accreditation, its instruments, its data and a handful of people who hold critical methods in their heads. Here are the red flags that most often surprise buyers after close.

Accreditation and compliance

1. Revenue outside the accreditation scope

Compare the revenue mix to the lab's scope of accreditation, test by test. Revenue from methods not on scope is at risk if customers require accredited results.

2. Open or recurring assessment findings

Ask for the last two or three assessment reports and customer audit reports. One finding is normal. The same finding across cycles signals a quality system that fixes symptoms, not causes.

3. Change-of-ownership risk to accreditation

Most accreditation bodies require notification of changes in ownership or legal status and may reassess. Biopharma QC labs may also need to update customer quality agreements and regulatory registrations. Build the timeline into the deal plan.

4. Proficiency testing failures

Repeated unsatisfactory proficiency testing results are an early warning that results may not hold up, and accreditation bodies treat them seriously.

Instruments and capacity

5. Instrument age and end of support

Map critical instruments against manufacturer end-of-support dates. A fleet that looks fully depreciated may hide a large capex wall in years one to three.

6. Calibration and maintenance backlog

Overdue calibrations and deferred maintenance flatter short-term margins and create both compliance and downtime risk.

7. Real versus reported capacity

Reported utilization often ignores downtime, calibration windows and qualification constraints. True available capacity determines whether the growth plan is realistic without new capex.

People and data

8. Key-person dependency

Count how many analysts are authorized on each revenue-critical method. If one or two people hold a high-margin method, that's a retention and continuity risk.

9. Data integrity gaps

Look for shared logins, disabled audit trails, results kept in uncontrolled spreadsheets and paper worksheets transcribed by hand. In GMP labs these are inspection risks. In any lab they are customer trust risks.

10. Unsupported IT on instrument PCs

Instrument controllers often run outdated operating systems that can't be patched without revalidation. Assess the cybersecurity exposure and the cost to remediate.

Margin and customers

11. Hidden retest and rework rate

Retests, reruns and corrections consume labor, consumables and capacity without new revenue. Few labs report this rate, so ask for it directly.

12. Turnaround reliability against commitments

Compare promised and actual turnaround time by customer and test type. Chronic delays drive churn that won't show in historical revenue until it's too late.

What to request in the data room

  • Scope of accreditation and the last three assessment reports with closure evidence.
  • Instrument register with age, service contracts, calibration status and end-of-support dates.
  • Training and authorization matrix by method.
  • Open deviations, CAPAs, OOS investigations and complaints, with aging.
  • Proficiency testing results for the last two years.
  • Turnaround time and retest data by test type.

FAQ

Does a lab's ISO 17025 accreditation transfer to a new owner?

Accreditation is granted to a legal entity at specific sites. A change of ownership usually requires notifying the accreditation body, which decides whether a reassessment is needed. Plan for it early.

How long does an operational lab diligence take?

A focused review of the areas above can usually be completed in about two weeks with access to the right records and people.

What's the most commonly missed lab risk?

Key-person dependency and instrument end-of-support are often missed because neither shows up in financial statements.

Related reading

Evaluating a lab acquisition? Trucision gives deal and operating teams a fast, record-level view of instrument health, compliance status and capacity. Book a 30-minute call.

Get started

Find the right plan to modernizeyour product line

We work with OEM product and service leaders to identify the highest-value starting pointy- whether that’s a specific instrument line, a service tier launch, or a compliance gap. Most engagement scope in one session.
Name *
Company
Email *
Role
What are you working on ? *

Thanks!
Your form has been submitted.

Please complete all mandatory fields before submitting.